Stay updated on Tislelizumab After Liver-Directed Therapy Clinical Trial

Sign up to get notified when there's something new on the Tislelizumab After Liver-Directed Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tislelizumab After Liver-Directed Therapy Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The 403 Forbidden page content and the Home link were removed from the page chrome. This represents a cleanup of non-core UI elements without modifying study details.
    Difference
    0.5%
    Check dated 2026-09-26T17:05:12.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record content. This indicates restricted access to the study details, with the header and footer remaining visible.
    Difference
    19%
    Check dated 2026-09-19T18:23:24.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.5 to v3.6.6. This reflects a minor update to the study details page without altering substantive content.
    Difference
    0.1%
    Check dated 2026-08-29T18:45:54.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    The page shows an updated site revision label, changing from Revision: v3.6.4 to Revision: v3.6.5, reflecting a backend/UI release. This update does not modify the study information or results.
    Difference
    0.1%
    Check dated 2026-08-08T18:45:39.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    The page’s revision marker updated from Revision: v3.6.3 to Revision: v3.6.4, indicating a new revision of the page has been published.
    Difference
    0.1%
    Check dated 2026-07-25T11:49:45.000Z thumbnail image
  7. Check
    96 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.2 to v3.6.3 on the page.
    Difference
    0.1%
    Check dated 2026-07-03T23:56:48.000Z thumbnail image

Stay in the know with updates to Tislelizumab After Liver-Directed Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tislelizumab After Liver-Directed Therapy Clinical Trial page.